ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 384,62
0,26%
Dow Jones
42 326,87
-2,58%
DAX
20 242,57
-0,05%
Brent Oil
72,825
0,12%
Bitcoin
100 981,11
0,92%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ

  6. Regulus Therapeutics Inc (RGLS) Cours

Regulus Therapeutics Inc

Regulus Therapeutics Inc (RGLS)

NASDAQ
1,51
-0,11
(-6,79%)
Fermé 19 Décembre 10:00PM
Retardé de 15 minutes
1,50
-0,01
(-0,66%)
Après les heures de négociation: 12:31AM
Retardé de 15 minutes

Votre Hub pour des idées et discussions en direct en temps réel

Premium

Statistiques et détails clés

Dernier
1,50
Prix Achat
1,50
Prix Vente
1,65
Volume échangé
232 683
1,50 Fourchette du Jour 1,64
1,08 Plage de 52 semaines 3,78
Cap du marché
98,25M
Clôture Veille
1,62
Ouverture
1,62
Dernière Transaction
500
@
1.5
(formt)
Dernière heure de transaction
Volume financier
US$ 368 598
VWAP
1,5841
Volume moyen (3 m)
335 021
Actions en circulation
65 500 134
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-3,29
Bénéfice par action (BPA)
-0,46
Chiffre d'affairess
-
Bénéfice net
-30,04M

À propos de Regulus Therapeutics Inc

Regulus Therapeutics Inc is a biotechnology company focused on the development of microRNA therapies. MicroRNA therapies target diseases such as cancer, metabolic diseases, fibrosis, and inflammatory diseases. MicroRNA is a noncoding ribonucleic acid that regulates most genes in the genome. The comp... Regulus Therapeutics Inc is a biotechnology company focused on the development of microRNA therapies. MicroRNA therapies target diseases such as cancer, metabolic diseases, fibrosis, and inflammatory diseases. MicroRNA is a noncoding ribonucleic acid that regulates most genes in the genome. The company partnered with Sanofi to create a compound targeting orphan diseases and with AstraZeneca to cure Type 2 Diabetes/prediabetes. Show more

Secteur
Pharmaceutical Preparations
Industrie
Pharmaceutical Preparations
Site Web
www.regulusrx.com
Siège social
Wilmington, Delaware, USA
Fondé
-
Regulus Therapeutics Inc est coté dans le secteur Pharmaceutical Preparations de la NASDAQ avec le ticker RGLS. Le dernier cours de clôture d'Regulus Therapeutics était de US$1,62. Au cours de la dernière année, les actions de Regulus Therapeutics ont été négociées dans une fourchette de prix de US$ 1,08 à US$ 3,78.

Regulus Therapeutics compte actuellement 65 500 134 actions en circulation. La capitalisation boursière d'Regulus Therapeutics est de US$106,11 million. Regulus Therapeutics a un ratio cours/bénéfice (ratio PE) de -3.29.

RGLS Dernières nouvelles

Plus de nouvelles

Regulus Therapeutics Announces Participation at Upcoming Healthcare Investment Conferences

Regulus Therapeutics Announces Participation at Upcoming Healthcare Investment Conferences PR Newswire SAN DIEGO, Nov. 26, 2024 SAN DIEGO, Nov. 26, 2024 /PRNewswire/ -- Regulus Therapeutics Inc...

26 Novembre 2024
PR Newswire (US)

Form SC 13G - Statement of Beneficial Ownership by Certain Investors

08 Novembre 2024
Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

07 Novembre 2024
Edgar (US Regulatory)

Form 8-K - Current report

07 Novembre 2024
Edgar (US Regulatory)

Regulus Therapeutics Reports Third Quarter 2024 Financial Results and Recent Updates

Regulus Therapeutics Reports Third Quarter 2024 Financial Results and Recent Updates PR Newswire SAN DIEGO, Nov. 7, 2024 Completed enrollment in the fourth cohort of the Phase 1b...

07 Novembre 2024
PR Newswire (US)

Form 8-K - Current report

24 Octobre 2024
Edgar (US Regulatory)

Form SC 13G - Statement of Beneficial Ownership by Certain Investors

24 Octobre 2024
Edgar (US Regulatory)

Form SC 13G - Statement of Beneficial Ownership by Certain Investors

11 Octobre 2024
Edgar (US Regulatory)

Regulus Therapeutics Announces Completion of Enrollment in Fourth Cohort of Phase 1b Multiple-Ascending Dose (MAD) Clinical Trial of RGLS8429 for the Treatment of Patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD)

Regulus Therapeutics Announces Completion of Enrollment in Fourth Cohort of Phase 1b Multiple-Ascending Dose (MAD) Clinical Trial of RGLS8429 for the Treatment of Patients with Autosomal Dominant...

08 Octobre 2024
PR Newswire (US)

Regulus Therapeutics Announces Participation at Two Healthcare Investment Conferences

Regulus Therapeutics Announces Participation at Two Healthcare Investment Conferences PR Newswire SAN DIEGO, Aug. 28, 2024 SAN DIEGO, Aug. 28, 2024 /PRNewswire/ -- Regulus Therapeutics Inc...

28 Août 2024
PR Newswire (US)
PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
1-0.17-10.17964071861.671.771.53369711.64330539CS
40.085.63380281691.421.771.32550361.58855984CS
12-0.01-0.6622516556291.511.81.33350211.54566751CS
26-0.88-36.9747899162.382.591.35681571.80819728CS
520.1511.11111111111.353.781.0811205972.2207794CS
1561.158338.5964912280.3423.780.15767658771.41001286CS
2600.9015150.6265664160.59853.780.157611757831.17658316CS

RGLS - Frequently Asked Questions (FAQ)

What is the current Regulus Therapeutics share price?
The current share price of Regulus Therapeutics is US$ 1,50
How many Regulus Therapeutics shares are in issue?
Regulus Therapeutics has 65 500 134 shares in issue
What is the market cap of Regulus Therapeutics?
The market capitalisation of Regulus Therapeutics is USD 106,11M
What is the 1 year trading range for Regulus Therapeutics share price?
Regulus Therapeutics has traded in the range of US$ 1,08 to US$ 3,78 during the past year
What is the PE ratio of Regulus Therapeutics?
The price to earnings ratio of Regulus Therapeutics is -3,29
What is the reporting currency for Regulus Therapeutics?
Regulus Therapeutics reports financial results in USD
What is the latest annual profit for Regulus Therapeutics?
The latest annual profit of Regulus Therapeutics is USD -30,04M
What is the registered address of Regulus Therapeutics?
The registered address for Regulus Therapeutics is CORPORATION TRUST CENTER, 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
What is the Regulus Therapeutics website address?
The website address for Regulus Therapeutics is www.regulusrx.com
Which industry sector does Regulus Therapeutics operate in?
Regulus Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
LITMSnow Lake Resources Ltd
US$ 0,7943
(334,04%)
1,2B
NUKKNukkleus Inc
US$ 50,68
(326,60%)
54,52M
PLRZPolyrizon Ltd
US$ 3,256
(210,10%)
137,32M
QMCOQuantum Corporation
US$ 60,085
(153,31%)
22,66M
VRARGlimpse Group Inc
US$ 3,1885
(100,53%)
55,04M
XCHXCHG Ltd
US$ 2,16
(-90,74%)
11,17M
FTELFitell Corporation
US$ 5,50
(-85,67%)
1,68M
XHGXChange TED Inc
US$ 0,754
(-52,28%)
549,34k
MHUAMeihua International Medical Technologies Company Ltd
US$ 0,2755
(-43,82%)
8,86M
RNAZTransCode Therapeutics Inc
US$ 3,915
(-38,00%)
854,5k
LITMSnow Lake Resources Ltd
US$ 0,7943
(334,04%)
1,2B
TNXPTonix Pharmaceuticals Holding Corporation
US$ 0,3671
(9,94%)
317,96M
CGTXCognition Therapeutics Inc
US$ 0,58295
(28,15%)
287,37M
RGTIRigetti Computing Inc
US$ 10,684
(-4,01%)
280,37M
NVDANVIDIA Corporation
US$ 128,91
(-1,14%)
277,36M

Forums

Afficher les forums
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

NASDAQ
RGLS
Regulus Therapeutics
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés